Funnelfeedr Logo

Key2Brain AB

Sweden559239-8746Active

Developing proprietary technology for next-generation brain targeting therapeutics.

Biotechnology Companykey2brain.se

Overview

10–19
Employees
2.5–5M SEK
Revenue
2020
Founded

Description

Key2Brain is a Swedish biotechnology company focused on developing next-generation therapies designed to treat severe diseases affecting the brain. Their core offering is a groundbreaking proprietary technology platform engineered to facilitate efficient uptake and broad distribution of therapeutics...

Tags

B2BPharmaceuticalsProfessional ServicesWhite Collar

Keywords

BBB CrossingBiotechBrain TargetingDrug DeliveryTherapeuticsVHH Antibodies

Company Information

Industry
Bioteknisk forskning och utveckling
Legal Form
Aktiebolag
VAT Number
SE559239874601

Decision Makers

No decision makers found yet

Similar Companies

20 similar companies in Funnelfeedr

SEAAX Biotech AB

5–9 employees

Research-driven biotech advancing antibody therapies via proprietary technology.

SEIRLAB Therapeutics AB

1–4 employees

Developing novel CNS drugs for Parkinson's disease using proprietary technology.

SEAffibody AB

50–99 employees

Developing next-generation radiopharmaceuticals using proprietary Affibody technology.

SEUppsala Therapeutics AB

0 employees

Developing nanoparticle platforms for targeted drug delivery across the BBB.

SEGrespo AB

0 employees

Young biomedical company developing CNS treatments based on 2-oxoglutarate research.

Browse More

Top Pharmaceuticals companies in Sweden

Key2Brain AB Questions

Want to see Funnelfeedr in action?

Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.

Book a demo